<DOC>
	<DOCNO>NCT02220439</DOCNO>
	<brief_summary>This proposal nest case‐control study within ongoing rotavirus vaccine immunogenicity clinical trial Karachi , Pakistan . The primary study aim compare fecal microbiota composition diversity infant ( control ) ( case ) demonstrate immune seroconversion rotavirus vaccination . The infant match vaccination dose , age breast‐feeding practice .</brief_summary>
	<brief_title>Does Fecal Microbiome Influence Rotarix Immunogenicity</brief_title>
	<detailed_description />
	<mesh_term>Rotavirus Infections</mesh_term>
	<mesh_term>Dysbiosis</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Immunoglobulin A</mesh_term>
	<criteria>6 week 0 day 7 week 6 day age time enrollment . Healthy infant free chronic serious medical condition determine history physical exam time enrollment study . Written inform consent obtain parent guardian . Availability baseline fecal sample collect Rotarix vaccination Written inform consent obtain parent guardian nest study Hypersensitivity vaccine component Use investigational drug vaccine study vaccine within 30 day first dose study vaccine study . Use immunosuppressive drug . Previous intussusception abdominal surgery . Enrollment trial ( besides NCT01199874 ) . Birth weight less 1500 gram ; birth weight unknown , weight less 2000 gram 28 day . Immunoglobulin and/or blood product use since birth study period . Nested study additional exclusion criterion : Positive serum anti‐rotavirus Immunoglobulin A ( &gt; 20 U/ml ) 6 week age , indicative prior rotavirus infection</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>rotavirus</keyword>
	<keyword>immunogenicity</keyword>
	<keyword>enteric vaccine</keyword>
	<keyword>vaccine immunogenicity</keyword>
	<keyword>rotavirus vaccine</keyword>
	<keyword>gut microbiome</keyword>
	<keyword>microbiome</keyword>
</DOC>